Email This Release
Riassunto: Servier e Taiho Oncology presentano dati recenti su LONSURF® (trifluridina/tipiracil) all'ASCO 2019 Gastrointestinal Cancers Symposium (ASCO GI)
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
*
Enter security words: